Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Prion Developmental Laboratories (PDL) was a biotechnology company specializing in the design and manufacture of rapid diagnostic tests for Transmissible Spongiform Encephalopathies (TSEs). The company's primary focus was on detecting misfolded prion proteins in animals, specifically targeting Bovine Spongiform Encephalopathy (Mad Cow Disease) and Chronic Wasting Disease in deer and elk. PDL utilized proprietary manufacturing technology to produce cost-effective, laboratory-quality assays intended for use in both clinical and field settings. Originally a subsidiary of Efoora, Inc., the company was later involved in acquisition proceedings by Abviva following the parent company's entry into receivership. Its products were part of significant international evaluations for BSE testing in the early 2000s.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Prion Developmental Laboratories.